BluePrint molecular subtyping recognizes single and dual subtype tumors with consequences for therapeutic guidance. (October 2020) - Ellappalayam, A.; Kuilman, M.; Mittempergher, L.; Wehkamp, D.; Chan, B.; Bhaskaran, R.; Glas, A.